drugset / Trial / NCT05258773
Evaluation of the Presence of SENS-401 in the Perilymph
RandomizedParallel-groupOpen-labelBasic science
Summary
The aim of this study is to detect the presence of SENS-401 in the perilymph of participants undergoing cochlear implant surgery after 7 days of oral administration of SENS-401.
Timeline
- Start
- 2022-08-10
- Primary completion
- 2023-12-18
- Completion
- 2024-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SENS-401 | Unknown | 43.5 mg | Oral |